京運通(601908.SH):子公司與天合光能簽訂約24.51億元單晶硅片採購框架合同
格隆匯3月1日丨京運通(601908.SH)公佈,公司全資子公司無錫京運通於2022年3月1日與天合光能簽訂了《單晶硅片採購框架合同》。天合光能擬於2022年3月至2022年12月向無錫京運通採購2.90億片單晶硅片。
按照當前市場價格(參照PVInfoLink最新公佈的單晶硅片均價折算)測算,預計銷售金額總計約24.51億元人民幣(含税)。上述銷售金額不構成業績承諾或業績預測,實際採購價格採取月度議價方式,合同交易總額以最終成交金額為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.